Image

Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU

Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

In septic shock there is growing evidence of a state of hemodynamic "disconnection" with seemingly adequate macrocirculatory values despite actual microcirculation failing to meet cellular demand. Norepinephrine (NE) is recommended as first choice vasoactive agent for the treatment of septic shock. However, the dynamic effects of NE on macro- and microcirculation and perfusion parameters has not been described in detail in the context of septic shock, precluding rational individualized titration of NE and fluids, as recommended recently. In the present prospective observational multicenter study in adult septic shock patients, we intend to explore the effects of NE on preload dependency and tissue perfusion by evaluating the correlation and potential discrepancies between macro- and microcirculation both during titration of NE and after fluid resuscitation. The conclusions drawn from our study will contribute to the physiological knowledge necessary for establishing individualized evidence-based bedside management of hemodynamics in the setting of septic shock.

Eligibility

Inclusion Criteria:

  • Suspected or documented infection
  • Need for vasopressors to maintain mean arterial blood pressure (MAP) ≥65 mmHg
  • Serum lactate levels >2 mmol/L
  • Norepinephrine infusion of > 0.2 mcg/kg/min

Exclusion Criteria:

  • Absolute contraindication for esophageal doppler or urinary catheter insertion as noted in the patients' charts.
  • Severe valvular pathology and cardiac arrhythmias resulting in severe hemodynamic instability.
  • Lithium treatment
  • Treatment with other vasopressor or inotropic drugs.

Study details
    Septic Shock
    Hemodynamic Instability
    Vasoconstriction

NCT05225402

Copenhagen University Hospital, Hvidovre

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.